MedBioSphere
Articles Videos The Web  
    

Search Results rifampicin

1. rifampicin
rifampicin (rif- am -pi-sin) n. an antibiotic administered by mouth to treat various infections, particularly tuberculosis and leprosy. Trade names: Rifadin, Rimactane.
January 1, 2008; A Dictionary of Nursing

2. Treatment of actinomycetoma with combination of rifampicin and co-trimoxazole
...report the efficacy of the combination of rifampicin and cotrimoxazole in a case of actinomycetoma...history of tuberculosis. He was started on rifampicin 600 mg daily and cotrimoxazole double...effects of the medication were seen. Rifampicin is a highly bactericidal antibiotic...
March 1, 2008; Indian Journal of Dermatology, Venereology and Leprology

3. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay
...limited treatment options. Resistance to rifampicin results from nucleotide changes in the...rpoB) of Mycobacteriume tuberculosis Rifampicin resistance is considered as a marker...frequency of mutations in the rpoB gene of rifampicin resistant clinical isolates vary considerably...
February 1, 2003; Indian Journal of Medical Research

4. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis
...drug resistance to important drugs like rifampicin. The present study was aimed at evaluation...correlate these mutations with levels of rifampicin resistance for assessing their clinical...subjected to susceptibility testing for rifampicin at various concentrations of drug viz...
August 1, 2004; Indian Journal of Medical Research

5. Rifampicin resistance in tuberculosis outbreak, London, England.(DISPATCHES)
...isoniazid-resistant M. tuberculosis outbreak acquired rifampicin resistance. The rpoB gene sequence showed...isolates had a mutation outside the rifampicin resistance-determining region...outbreak had developed resistance to rifampicin. Initially, the isolate was tested with...
June 1, 2005; Emerging Infectious Diseases

6. Effect of rifampicin & isoniazid on cytochrome P-450 in mycobacteria
Background & objectives: Rifampicin and isoniazid are the most important...bacteria. We report the effect of rifampicin and isoniazid on the cytochrome...Subinhibitory concentrations of rifampicin and isoniazid were added to the...
October 1, 2002; Indian Journal of Medical Research

7. Rifampicin-carrying poly(D,L-lactide) microspheres: loading and release
Rifampicin-loaded polylactide micro- spheres degraded much faster in the medium at basic pH and at high temperatures. Rifampicin Release was high under these conditions. It was concluded that rifampicin release was both degradation and diffusion-controlled. Rifampicin-loaded polylactide...
May 1, 1995; Biomedical Materials

8. Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs
...Objectives: Poor bioavailability of rifampicin (R) in combination with other anti-tuberculosis...bioavailability of R. Key words Bioavailability - rifampicin - treatment - tuberculosis - urinary...of multiple drug regimens containing rifampicin (R) in addition to ethambutol (E), isoniazid...
September 1, 2003; Indian Journal of Medical Research

9. Comparison of different merthods of assessing in vitro resistance of Mycobacterium tuberculosis to rifampicin
...Definitions of in vitro resistance to rifampicin in strains of Mycobacterium tuberculosis...methods of defining in vitro resistance to rifampicin. Methods: (i) A total of 598 clinical...definitions - Mycobacterium tuberculosis - rifampicin The standardization of drug susceptibility...
December 1, 2001; Indian Journal of Medical Research

10. Informal consultation on rifampicin resistance in leprosy.(Clinical report)
...recent findings from centres assessing rifampicin resistance. 3. To recommend reliable tools and procedures for surveillance of rifampicin resistance. 4. To consider methods for...consider alternate regimens without rifampicin as and when needed. Individuals and...
September 1, 2007; Leprosy Review